A Phase I Randomized, Observer-Blind, Controlled, Dose Escalation Trial of the Safety and Tolerability of Two Intramuscular Doses of DPX-RSV(A), a Respiratory Syncytial Virus (RSV) Vaccine Containing RSV SH Antigen and a Novel Adjuvant DepoVax, or SH Antigen Co-administered With Aluminum Hydroxide, or Placebo to Healthy Adults ≥50–64 Years of Age
Langley, Joanne, Macdonald, Lisa, Weir, Genevieve, Mackinnon-Cameron, Donna, Ye, Lingyun, McNeil, Shelly, Schepens, Bert, Saelens, Xavier, Stanford, Marianne, Halperin, ScottVolume:
3
Language:
english
Journal:
Open Forum Infectious Diseases
DOI:
10.1093/ofid/ofw172.973
Date:
December, 2016
File:
PDF, 66 KB
english, 2016